Application of ion exchange and extraction chromatography to the separation of actinium from proton-irradiated thorium metal for analytical purposes

Application of ion exchange and extraction chromatography to the separation of actinium from proton-irradiated thorium metal for analytical purposes

•Actinium-225 (t1/2=9.92d) is an α-emitting radionuclide for use in targeted alpha therapy.•During proton irradiation of thorium metal, long-lived 227Ac (t1/2=21.8a) is co-produced.•An efficient Ac/Th separation procedure is required for rapid 225Ac/227Ac ratio determination.•For Ac isolation, a seq...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Chromatography Vol. 1380; no. C; pp. 55 - 63
Main Authors: Radchenko, V., Engle, J.W., Wilson, J.J., Maassen, J.R., Nortier, F.M., Taylor, W.A., Birnbaum, E.R., Hudston, L.A., John, K.D., Fassbender, M.E.
Format: Journal Article
Language:English
Published: Netherlands Elsevier B.V 06-02-2015
Elsevier
Subjects:
Actinium
Actinium - isolation & purification
Actinium isotopes
Byproducts
Chromatography
Chromatography, Ion Exchange
Extraction
Extraction chromatography
Humans
Ion exchange
Isotopes
Lanthanide separation
Liquid-Liquid Extraction
Mathematical analysis
Protons
RADIATION CHEMISTRY, RADIOCHEMISTRY, AND NUCLEAR CHEMISTRY
RADIOLOGY AND NUCLEAR MEDICINE
Separation
Thorium
Thorium - isolation & purification
Thorium - radiation effects
Thorium chelation
Thorium chelationIon exchange
Thorium metal
Thorium chelation
Ion exchange
Thorium metal
Actinium isotopes
Extraction chromatography
Lanthanide separation
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Actinium-225 (t1/2=9.92d) is an α-emitting radionuclide for use in targeted alpha therapy.•During proton irradiation of thorium metal, long-lived 227Ac (t1/2=21.8a) is co-produced.•An efficient Ac/Th separation procedure is required for rapid 225Ac/227Ac ratio determination.•For Ac isolation, a sequence of cation exchange and extraction chromatography was implemented.•Ac is isolated from Th and then purified from fission lanthanides via extraction chromatography. Actinium-225 (t1/2=9.92d) is an α-emitting radionuclide with nuclear properties well-suited for use in targeted alpha therapy (TAT), a powerful treatment method for malignant tumors. Actinium-225 can also be utilized as a generator for 213Bi (t1/2 45.6min), which is another valuable candidate for TAT. Actinium-225 can be produced via proton irradiation of thorium metal; however, long-lived 227Ac (t1/2=21.8a, 99% β−, 1% α) is co-produced during this process and will impact the quality of the final product. Thus, accurate assays are needed to determine the 225Ac/227Ac ratio, which is dependent on beam energy, irradiation time and target design. Accurate actinium assays, in turn, require efficient separation of actinium isotopes from both the Th matrix and highly radioactive activation by-products, especially radiolanthanides formed from proton-induced fission. In this study, we introduce a novel, selective chromatographic technique for the recovery and purification of actinium isotopes from irradiated Th matrices. A two-step sequence of cation exchange and extraction chromatography was implemented. Radiolanthanides were quantitatively removed from Ac, and no non-Ac radionuclidic impurities were detected in the final Ac fraction. An 225Ac spike added prior to separation was recovered at ≥98%, and Ac decontamination from Th was found to be ≥106. The purified actinium fraction allowed for highly accurate 227Ac determination at analytical scales, i.e., at 227Ac activities of 1–100kBq (27nCi to 2.7μCi).
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
89233218CNA000001; AC52-06NA253996
LA-UR-14-26567
USDOE Office of Science (SC), Nuclear Physics (NP)
ISSN:0021-9673
1873-3778
DOI:10.1016/j.chroma.2014.12.045